Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study
暂无分享,去创建一个
E. Lespessailles | T. Barnetche | P. Hilliquin | A. Saraux | C. Roux | P. Fardellone | A. Constantin | R. Flipo | A. Baillet | E. Shipley | G. Baudens | I. Idier | Anika Gilbert-Marceau